2023 ´ëÇѼºÇü¿Ü°úÇÐȸ º¸Åø¸®´® ÇÊ·¯ ½Ç¸®ÇÁÆà ¿¬±¸È¸ Çмú ½ÉÆ÷Áö¾ö : 2023-09-24
±³À°ÀÏÀÚ : 2023-09-24
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ
±³À°ÁÖÁ¦ : 2023 ´ëÇѼºÇü¿Ü°úÇÐȸ º¸Åø¸®´® ÇÊ·¯ ½Ç¸®ÇÁÆà ¿¬±¸È¸ Çмú ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѼºÇü¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : º¸Å縮´® ÇÊ·¯ ½Ç¸®ÇÁÆà ¿¬±¸È¸(¸íĪº¯°æ 22.9.29 Åå½ÅÇÊ·¯¿¬±¸È¸)
´ã´çÀÚ : À±ÇÑ¿µ
¿¬¶ôó : 02-3472-4252
À̸ÞÀÏ : overmind119@naver.com
±³À°Á¾·ù : ¼ºÇü¿Ü°ú
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 5ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:00~09:10 ȸÀå °³È¸»ç ±èÁ¾¼(±èÁ¾¼¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:10~09:20 Speciallecture for BoFilTh Benjamin Archer(IMCAS Think-in)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:20~09:30 ÃʽÉÀÚ°¡ ¾Ë¾Æ¾ß ÇÒ Á¾¾Æ¸® º¸Å彺ÀÇ ¸ðµç°Í ¹Úµ¿±Ç(¾Æ¸óµå ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:30~09:40 ½Ç¸®ÇÁÆÃ, ÇÊ·¯, Åå½ÅÀÇ º¹Çսüú/ simple combination of thread, filler and toxin À±ÇÑ¿µ(ºêÀÌ ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:40~09:50 º¸Çü¹°º¸´Ù ´õ ¿¹»Û Åγ¡ ¸¸µé±â ÃÖµ¿Çå(·¿Ã÷ ¼ºÇü¿Ü°ú)
Åä·Ð 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:50~09:55 Åä·Ð ( )
ÈÞ½Ä 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 09:55~10:05 ÈÞ½Ä ( )
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:05~10:15 ´«½çÇÏ°Å»ó¼ö¼ú½Ã ´«¾Õ ÈäÅ͸¦ ÁÙÀ̱â À§ÇÑ º¸Å彺ÁÖ»ç ±èÀ¶¼ö(¼¿¶ó ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:15~10:25 ħ»ùº¸Å彺 ¹é¼ºÁ¾(û´ãŸÀÓ ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:25~10:35 ¸ñ¼±°ú ¾î²²¶óÀÎÀ» ¾Æ¸§´ä°Ô ¸¸µå´Â ½Â¸ð±Ù º¸Å彺 Á¤Çö¿í(½ºÄÉÄ¡ ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:35~10:45 Clinical trial of Botulinium toxin into Trapezius for contouring (´ëÇк´¿ø ½ÃÇà ½Â¸ð±Ù ¿¬±¸³í¹®) Á¤¿ì½Ä(¼¿ï¾Æ»êº´¿ø ¼ºÇü¿Ü°ú)
Åä·Ð 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:45~10:50 Åä·Ð ( )
ÈÞ½Ä 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 10:50~11:00 ÈÞ½Ä ( )
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:00~11:10 ÁøÈÇÏ´Â ½ºÅ²ºÎ½ºÅÍ ºñ±³Á¤¸®, È¿°úÀûÀÎ transdermal delivery¸¦ À§ÇÑ Á¶°Ç ( )
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:10~11:25 Reconstruction of Dermo epidermal junction with TargetCool and exosomes / Á¤¹Ð³Ã°¢Àåºñ ÀÌ¿ë ¿¢¼ÒÁ» Ä¡·á¿Í Á¶Á÷°Ë»ç¼Ò°ß ÀÌ¿µ¼·(2010 ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:25~11:35 ¿¢¼ÒÁ» ¸ð¹ßÄ¡·á ±âÃÊ, ¿¢¼ÒÁ»ÀÇ ÀÓ»óÀû Àû¿ë / Basic concept and research on exosome and hair & / Clinical application ¹Úº´Ã¶(´Ü±¹´ëÇб³º´¿ø ÇǺΰú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:35~11:50 UpdateµÈ PDRNÀÛ¿ë±âÀü ÃÑÁ¤¸® ÀÌÇѾó(¸®¾Ø¸® ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 11:50~12:00 Advanved cell & tissue therapjy for skin aging and lesions ¹ÚÀº¼ö(¼øõÇâ´ëÇб³º´¿ø ¼ºÇü¿Ü°ú)
Åä·Ð 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:00~12:05 Åä·Ð ( )
½Ä»ç 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:05~12:50 Á¡½É½Ä»ç ( )
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:50~13:10 Part 1. ÇÊ·¯½Ã¼ú¿¡ ²À ÇÊ¿äÇÑ ÃÊÀ½ÆÄÇغÎÇÐ (Part 2. º¸Å彺 Part 3. ½Ç¸®ÇÁÆÃ) ±èÈñÁø(¿¬¼¼´ëÄ¡´ë ÇغÎÇб³½Ç)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:10~13:20 Detailed anatomy of fat compatments and retaining ligaments in lower eyelid ¼º³«°ü(¼º³«°ü ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:20~13:30 ºÎÀ§º° (À̸¶, °üÀÚ, DMCF) ÇÊ·¯ ÃÊÀ½ÆÄ ÇغÎÇÐ ±èÁ¾¼(±èÁ¾¼ ¼ºÇü¿Ü°ú)
Åä·Ð 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:30~13:35 Åä·Ð ( )
ÈÞ½Ä 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:35~13:45 ÈÞ½Ä ( )
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:45~13:55 ´ÙÀ̳ª¹Í ´«¹ØÇÊ·¯ ½Ã¼ú¹ý°ú ¼ö¼úº´Çà¿ä¹ý ÃÖµ¿Çå(·¿Ã÷ ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:55~14:05 ´«¹ØÁö¹æÀ̽İú Á꺣·è º´ÇÕÀ» ÅëÇÑ ½Ã³ÊÁöÈ¿°ú ÀÌÇѾó(¸®¾Ø¸® ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:05~14:15 Polymers in cosmetic use; a review (¹Ì¿ë½Ã¼ú¿¡ »ç¿ëµÇ´Â Æú¸®¸Ó ¸®ºä) À̿켺(·ÎÁî ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:15~14:30 PDLA(Á꺣·è)°ú ¹Ì¶óÁ¬À» ÀÌ¿ëÇÑ ½Å°³³ä ÈäÅÍÄ¡·á & Á¶Á÷°Ë»ç¼Ò°ß ¼¼®¹è(¼¾Æ¼Û ÇǺΰú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:30~14:40 ½ºÄÃÆ®¶ó¸¦ ÀÌ¿ëÇÑ ÀÚ¿¬½º·¯¿î ¾ÈƼ¿¡ÀÌ¡ Â÷Á¾Çö(¿¥·¹µå ¼ºÇü¿Ü°ú)
Åä·Ð 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:40~14:45 Åä·Ð ( )
ÈÞ½Ä 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:45~14:55 ÈÞ½Ä ( )
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:55~15:10 ÇÊ·¯ ¾È¸éº¼·ý¾÷ 25³â °æÇèÀÇ ³ëÇÏ¿ì / Tips for facial volumization with fillers based on 25 years' experience. ¼±¸ÀÏ(¸ðµ¨·Î ÇǺΰú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:10~15:20 ÇغÎÇп¡ ±âÃÊÇÑ À̸¶, °üÀÚºÎÀ§ ÇÊ·¯Áֻ翡 ´ëÇÑ ³ª¸¸ÀÇ ÁÖ»ç¹ý /Anatomy based personal technique for forehead& temple injection ¾ÈÅÂÁÖ(¼ö¾ÆÀÌ ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:20~15:30 Filler treatments to delay facial aging ³ëȹæÁö¸¦ À§ÇÑ ÇÊ·¯½Ã¼ú ³ëÇÏ¿ì ÃÖ¿ø¼®(ºêÀÌ ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:30~15:40 Tear tough deformities, palpebromalar groove, antero-medial cheeks, Nasolabial fold Injections ±èÇöÁ¶(Â÷¾Ø¹Ú ÇǺΰú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:40~15:55 (1) Ãʺ¸µéµµ ½±°Ô ¾Ë¼ö ÀÖ´Â ÇÇºÎ¾Ï Áø´Ü¹ý (2) ÇǺι̿ë½Ã¼ú ÇÕº´ÁõÀÇ ´ëÇк´¿ø±Þ ÇǺΰú Ä¡·á ¹æ¹ý ³ëÇÏ¿ì °ø°³ ¿Àº´È£(¼¼ºê¶õ½ºº´¿ø ÇǺΰú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:55~16:05 CT/MRI Imaging Features of Injectable Fillers ¼º³«°ü(¼º³«°ü ¼ºÇü¿Ü°ú)
Åä·Ð 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:05~16:10 Åä·Ð ( )
ÈÞ½Ä 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:10~16:20 ÈÞ½Ä ( )
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:20~16:30 Monopolar RF: ½á¸¶ÁöFLX¸¦ ÀÌ¿ëÇÑ ºñħ½ÀÀû ¾È¸é tightening ¹× texture °³¼± ¼µ¿Çý(¾Æ·ë´Ù¿î³ª¶ó ÇǺΰú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:30~16:40 Simultaneous combination treatment with monopolar RF and 2-line HIPU for facial rejuvenation ¹ÚÀº¼ö(¼øõÇâ´ëÇб³º´¿ø ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:40~16:50 ¼ºÇü¼ö¼úÀ» º¸Á¶ÇÏ´Â ¿ªÇҷμÀÇ EBD ¼±ÅÃÇϱâ : 6.78MHz-¸ð³ëÆú¶ó-RF ±è±âÅÂ(Å ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:50~17:00 ÇǾƸð : Áøº¸µÈ À½¾Ð °íÁÖÆÄ Ä¡·á¸¦ ÀÌ¿ëÇÑ ¾ÈÀü, Æí¸®, È¿°úÀûÀÎ º¼»ìóÁü °³¼± ±Ç¿µ´ë(¿À»ê°³² ¼ºÇü¿Ü°ú)
Åä·Ð 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:00~17:05 Åä·Ð ( )
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:05~17:15 ¸ÅÃâÁõ´ë µµ¿òµÇ´Â Àë¹ö½Ç : ¸®ÇÁÆðú º¼·ý µÎ¸¶¸® Åä³¢Àâ±â ±Ç¿µ´ë(¿À»ê°³² ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:15~17:25 ¿ì¸® º´¿ø¿¡ ¸Â´Â ¸®ÇÁÆà ½Ç ¼¼ÆÃÇϱâ; 2024 guideline, ½Ç¸®ÇÁÆÃÀÇ À¯Áö±â°£À» ´Ã¸®±â À§ÇÑ µðÅ×ÀÏ ¹Ú¼ö¿¬(¸ÞÀ̵念 ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:25~17:35 Influencing factors on thread lifting longevity (½Ç¸®ÇÁÆà ½Ã¼úÀ» ¿À·¡ À¯ÁöÇÏ´Â ºñ¹ýÀº?) ¹Ú¿µÁø(°³²»ï¼º ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:35~17:45 ÆÈÀÚÁÖ¸§ÀÇ ½Ç¸®ÇÁÆà ±³Á¤,½Ç¸®ÇÁÆðú Áö¹æÈíÀÔ º¹Çսüú ÈÄ 3³âÀÌ»ó Áö¼ÓÈ¿°ú ¹é¼ºÁ¾(û´ãŸÀÓ ¼ºÇü¿Ü°ú)
Åä·Ð 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:45~17:50 Åä·Ð ( )
±âŸ 09¿ù 24ÀÏ ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:50~18:00 Æóȸ»ç & »çÁøÃÔ¿µ ( )